Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053762 · ClinicalTrials.gov registry record · NA
Identify the Usefulness of Peer-facilitated Versus Self-navigated Quit Tobacco Program for Youths.
A NA study of Tobacco Product Use, sponsored by Morgan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 630
- Enrollment target
- 1
- Study location
NCT06053762: Recruiting NA study of Tobacco Product Use, sponsored by Morgan State University.
NCT06053762 is a NA study of Tobacco Product Use that is actively recruiting participants, run by Morgan State University. The registered enrollment target is 630 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053762, a NA study of Tobacco Product Use, is actively recruiting participants, sponsored by Morgan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 630 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is a randomized clinical trial. The overarching goal of the study is to apply Community Based Participatory Research (CBPR) to reduce tobacco use among youth and young adults (14-21 y/o) in Baltimore City through a mixed-method approach adapted to the needs of youth and young adults. This study has partnered with the American Lung Association's Not On Tobacco (N-O-T) program and aims to deliver tobacco cessation classes. The study will target Baltimore City high schools and colleges, prioritizing facilities in underserved inner-city communities. The proposed research consists of a 2-arm trial where participants from four high schools and two colleges will be randomized to peer-facilitated tobacco cessation classes or self-navigated groups. The trial aims to assess the effectiveness of peer-facilitated tobacco cessation intervention compared to self-navigated tobacco cessation in terms of their success rates (quitting and staying quit). The study's primary hypothesis is that the tobacco cessation rate will be equal to or higher in the peer-facilitated arm than in the self-navigated arms. The secondary hypothesis is that the retention rate will be equal to or higher in the peer-facilitated arm compared to the self-navigated arm. CEASE Youth tobacco cessation program is an eight-week program based on the American Lung Association's (ALA) Not On Tobacco (N-O-T) program. The ALA's N-OT program is acknowledged as an accessible and effective option for teen tobacco cessation. Participants in the peer-facilitated group will be given the evidence-based N-O-T program curriculum and provided with virtual materials, information, and resources by their assigned peer facilitators. Virtual tobacco cessation peer motivation sessions will be offered using the digital online platform Zoom, and the peer facilitators will communicate with the participants in between the classes. The participants in the self-navigated group will receive the same ALA N-O-T program cur
Conditions Studied
Interventions
- BEHAVIORAL Peer-facilitated tobacco cessation
- BEHAVIORAL Self-navigated tobacco cessation
Study Locations (1)
Maryland
- Morgan CARES - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What NCT06053762 shows while recruiting
NCT06053762 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Tobacco Product Use appearing as the primary indexed condition, and to 2 interventions - of which Peer-facilitated tobacco cessation is the first listed.
NCT06053762 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06053762 about?
NCT06053762 is a clinical study titled "Identify the Usefulness of Peer-facilitated Versus Self-navigated Quit Tobacco Program for Youths.". The proposed study is a randomized clinical trial. The overarching goal of the study is to apply Community Based Participatory Research (CBPR) to reduce tobacco use among youth and young adults (14-21 y/o) in Baltimore City through a mixed-method approach adapted to the needs of youth and young adul...
What is the current status of trial NCT06053762?
This trial is currently recruiting. It is a NA study. The enrollment target is 630 participants. The study started on 2023-10-01. Estimated completion is 2024-12-01.
What conditions does trial NCT06053762 study?
This clinical trial studies the following conditions: Tobacco Product Use.
What interventions are being tested in trial NCT06053762?
The interventions under investigation include: Peer-facilitated tobacco cessation (BEHAVIORAL), Self-navigated tobacco cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06053762?
This trial is sponsored by Morgan State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053762 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06053762's enrollment target sits among peer trials
630 159th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI